BRAF V600E Status Alone Is Not Sufficient As a Prognostic Biomarker in Pediatric Low-Grade Glioma
Overview
Authors
Affiliations
Multimodal deep learning improves recurrence risk prediction in pediatric low-grade gliomas.
Mahootiha M, Tak D, Ye Z, Zapaishchykova A, Likitlersuang J, Climent Pardo J Neuro Oncol. 2024; 27(1):277-290.
PMID: 39211987 PMC: 11726244. DOI: 10.1093/neuonc/noae173.
Lorincz K, Gorodezki D, Schittenhelm J, Zipfel J, Tellermann J, Tatagiba M Childs Nerv Syst. 2024; 40(10):3037-3050.
PMID: 39145885 PMC: 11511697. DOI: 10.1007/s00381-024-06561-y.
Gorodezki D, Schuhmann M, Ebinger M, Schittenhelm J Cells. 2024; 13(14.
PMID: 39056798 PMC: 11274692. DOI: 10.3390/cells13141215.
Classification and Treatment of Pediatric Gliomas in the Molecular Era.
Hauser P Children (Basel). 2021; 8(9).
PMID: 34572171 PMC: 8464723. DOI: 10.3390/children8090739.
Reimagining pilocytic astrocytomas in the context of pediatric low-grade gliomas.
Milde T, Rodriguez F, Barnholtz-Sloan J, Patil N, Eberhart C, Gutmann D Neuro Oncol. 2021; 23(10):1634-1646.
PMID: 34131743 PMC: 8485452. DOI: 10.1093/neuonc/noab138.